H2AFV expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.886400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.180800E-01
Normal-vs-Stage2
6.989000E-01
Normal-vs-Stage3
4.266200E-01
Normal-vs-Stage4
4.289000E-01
Stage1-vs-Stage2
8.374200E-01
Stage1-vs-Stage3
2.050400E-01
Stage1-vs-Stage4
4.227200E-01
Stage2-vs-Stage3
1.334600E-01
Stage2-vs-Stage4
4.835800E-01
Stage3-vs-Stage4
1.822960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.944000E-01
Normal-vs-AfricanAmerican
3.342400E-01
Normal-vs-Asian
9.027600E-01
Caucasian-vs-AfricanAmerican
7.330800E-01
Caucasian-vs-Asian
7.092800E-01
AfricanAmerican-vs-Asian
6.019600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.415800E-01
Normal-vs-Female
6.265400E-01
Male-vs-Female
4.442200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.789200E-01
Normal-vs-Age(41-60Yrs)
3.157200E-01
Normal-vs-Age(61-80Yrs)
8.943200E-01
Normal-vs-Age(81-100Yrs)
8.419600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.311000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.231400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.016600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.361800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.780100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.847600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.284400E-01
Normal-vs-Daily Drinker
8.768600E-01
Normal-vs-Weekly Drinker
7.927000E-01
Normal-vs-Occasional Drinker
2.813200E-01
Normal-vs-Social Drinker
5.148400E-01
Non Drinker-vs-Daily Drinker
4.360400E-01
Non Drinker-vs-Weekly Drinker
4.274000E-01
Non Drinker-vs-Occasional Drinker
8.899400E-03
Non Drinker-vs-Social Drinker
6.255900E-02
Daily Drinker-vs-Weekly Drinker
7.272200E-01
Daily Drinker-vs-Occasional Drinker
6.752300E-02
Daily Drinker-vs-Social Drinker
2.317400E-01
Weekly Drinker-vs-Occasional Drinker
3.771600E-01
Weekly Drinker-vs-Social Drinker
5.949800E-01
Occasional Drinker-vs-Social Drinker
7.845200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.882600E-01
Normal-vs-Grade 2
8.675000E-01
Normal-vs-Grade 3
8.844800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.352400E-01
Grade 1-vs-Grade 3
9.389600E-01
Grade 1-vs-Grade 4
8.882600E-01
Grade 2-vs-Grade 3
4.700600E-01
Grade 2-vs-Grade 4
8.675000E-01
Grade 3-vs-Grade 4
8.844800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.037600E-01
Normal-vs-NonDiabetic
6.226600E-01
Diabetic-vs-NonDiabetic
5.478400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.764000E-01
Normal-vs-NoPancreatitis
7.107400E-01
Pancreatitis-vs-NoPancreatitis
8.381600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.189600E-01
Normal-vs-N1
7.006800E-01
N0-vs-N1
9.343000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.539800E-01
Normal-vs-TP53-NonMutant
8.470800E-01
TP53-Mutant-vs-TP53-NonMutant
2.662300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
